Ranitidine hydrochloride and Hypoglycemia - a phase IV clinical study of FDA data
Hypoglycemia is found among people who take Ranitidine hydrochloride, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Ranitidine hydrochloride and have Hypoglycemia. It is created by eHealthMe based on reports of 66,984 people who have side effects when taking Ranitidine hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
66,984 people reported to have side effects when taking Ranitidine hydrochloride.
Among them, 29 people (0.04%) have Hypoglycemia.
What is Ranitidine hydrochloride?
Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 67,576 Ranitidine hydrochloride users for its effectiveness, alternative drugs and more.
What is Hypoglycemia?
Hypoglycemia (low blood sugar) is found to be associated with 2,812 drugs and 2,281 conditions by eHealthMe.
Number of Ranitidine hydrochloride and Hypoglycemia reports submitted per year:
Time on Ranitidine hydrochloride when people have Hypoglycemia *:
- < 1 month: 75 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 25 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hypoglycemia when taking Ranitidine hydrochloride *:
- female: 71.43 %
- male: 28.57 %
Age of people who have Hypoglycemia when taking Ranitidine hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 10 %
- 50-59: 25 %
- 60+: 65 %
Common drugs people take besides Ranitidine hydrochloride *:
- Furosemide: 14 people, 48.28%
- Lisinopril: 10 people, 34.48%
- Humira: 10 people, 34.48%
- Methotrexate: 10 people, 34.48%
- Prednisone: 9 people, 31.03%
- Amlodipine Besylate: 4 people, 13.79%
- Losartan Potassium: 4 people, 13.79%
- Allopurinol: 3 people, 10.34%
- Spironolactone: 3 people, 10.34%
- Cilostazol: 3 people, 10.34%
Common side effects people have besides Hypoglycemia *:
- Histiocytosis Haematophagic: 10 people, 34.48%
- Bacteraemia (presence of bacteria in the blood): 9 people, 31.03%
- Disseminated Tuberculosis: 8 people, 27.59%
- Klebsiella Infection: 6 people, 20.69%
- Infection: 6 people, 20.69%
- Blood Lactate Dehydrogenase Increased: 5 people, 17.24%
- Anaemia (lack of blood): 4 people, 13.79%
- Overdose: 3 people, 10.34%
- Hypotension (abnormally low blood pressure): 3 people, 10.34%
- Blood Ph Increased: 3 people, 10.34%
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 34.48%
- High Blood Pressure: 5 people, 17.24%
- Cardiac Failure: 4 people, 13.79%
- Diabetes: 4 people, 13.79%
- Pneumonia: 3 people, 10.34%
- Ulcer Haemorrhage (bleeding ulcer): 2 people, 6.90%
- Shunt Stenosis (narrowing of shunt): 2 people, 6.90%
- Renal Failure Chronic (long lasting kidney dysfunction): 2 people, 6.90%
- Ill-Defined Disorder: 2 people, 6.90%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.45%
* Approximation only. Some reports may have incomplete information.
Do you take Ranitidine hydrochloride and have Hypoglycemia?Check whether Hypoglycemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
How severe was Hypoglycemia and when was it recovered:
Expand to all the drugs that have ingredients of ranitidine hydrochloride:
Alternative drugs to, pros and cons of Ranitidine hydrochloride:
- Ranitidine hydrochloride (67,576 reports)
Common Ranitidine hydrochloride side effects:
- Breast cancer: 9,833 reports
- Prostate cancer: 9,230 reports
- Colon cancer: 7,581 reports
- Renal cell carcinoma (a kidney cancer): 7,071 reports
- Bladder cancer: 5,798 reports
- Gastric cancer (stomach cancer): 2,606 reports
- Pancreatic carcinoma (pancreatic cancer): 2,583 reports
- Chronic kidney disease: 1,307 reports
Browse all side effects of Ranitidine hydrochloride:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hypoglycemia treatments and more:
- Hypoglycemia (52,267 reports)
COVID vaccines that are related to Hypoglycemia:
- Hypoglycemia in Moderna COVID Vaccine
- Hypoglycemia in Pfizer BioNTech Covid Vaccine
- Hypoglycemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypoglycemia:
- Metformin: 8,660 reports
- Lantus: 7,019 reports
- Humalog: 3,786 reports
- Aspirin: 3,158 reports
- Furosemide: 2,284 reports
- Lasix: 2,051 reports
- Novorapid: 1,962 reports
- Amlodipine: 1,836 reports
- Amaryl: 1,831 reports
- Simvastatin: 1,827 reports
All the drugs that are associated with Hypoglycemia:
- Hypoglycemia (2,812 drugs)
Common conditions associated with Hypoglycemia:
- Type 2 diabetes: 8,891 reports
- Diabetes: 8,036 reports
- High blood pressure: 4,077 reports
- Type 1 diabetes: 2,482 reports
- Depression: 1,270 reports
- Pain: 1,018 reports
All the conditions that are associated with Hypoglycemia:
- Hypoglycemia (2,281 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Ranitidine hydrochloride) and Ranitidine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zopiclone vs. Magnesium Citrate - 2 seconds ago
- Zantac 150 and Navelbine drug interaction - 2 seconds ago
- Buspar vs. Propranolol Hydrochloride - 5 seconds ago
- Unisom and Blindness - 9 seconds ago
- Benzonatate and Heart Rate Increased - 14 seconds ago
- Atrioventricular Block Complete and Bradycardia - 15 seconds ago
- Lorcet-Hd and Acne - 17 seconds ago
- Luvox and Cannabis drug interaction - 17 seconds ago
- Ceftriaxone Sodium and Reflux Oesophagitis - 19 seconds ago
- Gabapentin and Hepatic Infection - 29 seconds ago